TFS Chemicals - Aspire
Pharma Focus America
Sino Biological - Cytokine

Difgen Pharmaceuticals Acquires Krigen Pharmaceuticals Llc, Boosting Expertise in Complex Sterile Dosage Forms

Tuesday, December 12, 2023

DifGen Pharmaceuticals LLC has recently finalized the acquisition of KriGen LLC, a fully integrated sterile drug product manufacturer. KriGen's capabilities encompass the manufacturing of various parenteral products, including Aseptic and Terminally Sterilized Large Volume Parenteral (LVP) bags, Prefilled Syringes (PFS), Microspheres, and complex Long Acting Injectables.

In a joint statement, Ramandeep Singh Jaj and Dr. Santhanakrishnan Srinivasan, Founders and Co-CEOs of DifGen, expressed their excitement about this significant milestone. They highlighted the strategic importance of the acquisition, which enhances DifGen's scientific capabilities in developing intricate injectable products. The move enables DifGen to internally produce complex and high-barrier-to-entry sterile products, ensuring a local US-based supply for its partners. The founders emphasized the positive impact on providing patients with affordable, high-quality lifesaving medications and reducing the burden of drug shortages.

The completion of the transaction is pending customary regulatory approvals.



patheon - Mastering API production at every scaleWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Future Labs Live USA 2024patheon - Revolutionizing PharmaHealthcare CNO SummitHealthcare CMO Summit